Guillaume Goudot, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carotid Stenosis | 6 | 2023 | 854 | 1.820 |
Why?
|
Femoral Vein | 2 | 2020 | 159 | 1.280 |
Why?
|
Ultrasonic Therapy | 3 | 2023 | 235 | 1.120 |
Why?
|
Plaque, Atherosclerotic | 3 | 2023 | 1519 | 1.050 |
Why?
|
Endarterectomy, Carotid | 3 | 2023 | 546 | 0.850 |
Why?
|
Ergotism | 1 | 2021 | 4 | 0.790 |
Why?
|
Dihydroergotamine | 1 | 2021 | 20 | 0.780 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 2 | 2018 | 39 | 0.770 |
Why?
|
Nurse Practitioners | 1 | 2023 | 269 | 0.700 |
Why?
|
Elasticity Imaging Techniques | 2 | 2021 | 388 | 0.700 |
Why?
|
Venous Thrombosis | 2 | 2020 | 1239 | 0.700 |
Why?
|
Lipoprotein(a) | 1 | 2022 | 435 | 0.650 |
Why?
|
HIV Protease Inhibitors | 1 | 2021 | 430 | 0.640 |
Why?
|
Aortic Valve | 5 | 2023 | 1924 | 0.630 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2018 | 89 | 0.600 |
Why?
|
Carotid Artery, Common | 1 | 2018 | 183 | 0.600 |
Why?
|
Vasoconstrictor Agents | 1 | 2021 | 642 | 0.590 |
Why?
|
Extremities | 1 | 2022 | 866 | 0.590 |
Why?
|
Carotid Arteries | 4 | 2023 | 950 | 0.570 |
Why?
|
Angioplasty, Balloon | 1 | 2021 | 653 | 0.560 |
Why?
|
Aortic Valve Stenosis | 3 | 2023 | 1965 | 0.550 |
Why?
|
Heart Valve Prosthesis | 1 | 2023 | 1490 | 0.500 |
Why?
|
Ischemia | 2 | 2021 | 1907 | 0.490 |
Why?
|
Heart Valve Diseases | 2 | 2019 | 1074 | 0.460 |
Why?
|
Aorta, Thoracic | 1 | 2018 | 1084 | 0.410 |
Why?
|
Ultrasonography | 7 | 2023 | 5984 | 0.390 |
Why?
|
Ultrasonography, Doppler | 2 | 2023 | 458 | 0.360 |
Why?
|
Vascular Diseases | 1 | 2017 | 1161 | 0.330 |
Why?
|
Family | 2 | 2021 | 3147 | 0.320 |
Why?
|
Peripheral Arterial Disease | 3 | 2023 | 1188 | 0.310 |
Why?
|
Transducers | 2 | 2020 | 252 | 0.310 |
Why?
|
von Willebrand Factor | 2 | 2021 | 669 | 0.290 |
Why?
|
Fibrin Fibrinogen Degradation Products | 4 | 2022 | 426 | 0.290 |
Why?
|
Venous Thromboembolism | 4 | 2023 | 1671 | 0.290 |
Why?
|
Paris | 2 | 2022 | 42 | 0.270 |
Why?
|
Blood Pressure Determination | 2 | 2023 | 633 | 0.250 |
Why?
|
Physicians | 1 | 2023 | 4567 | 0.250 |
Why?
|
Endovascular Procedures | 2 | 2017 | 1980 | 0.240 |
Why?
|
Hypertension | 2 | 2018 | 8479 | 0.240 |
Why?
|
Physical Fitness | 1 | 2009 | 732 | 0.240 |
Why?
|
Blood Flow Velocity | 4 | 2021 | 1423 | 0.240 |
Why?
|
Swine | 3 | 2020 | 5918 | 0.210 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 2021 | 31 | 0.200 |
Why?
|
Sound | 1 | 2023 | 260 | 0.200 |
Why?
|
Thrombophilia | 2 | 2021 | 305 | 0.200 |
Why?
|
Tuberculosis, Cardiovascular | 1 | 2020 | 9 | 0.200 |
Why?
|
Nurse's Role | 1 | 2023 | 209 | 0.190 |
Why?
|
Iliac Aneurysm | 1 | 2020 | 38 | 0.190 |
Why?
|
Heart, Artificial | 1 | 2020 | 102 | 0.190 |
Why?
|
Splenic Artery | 1 | 2020 | 54 | 0.190 |
Why?
|
Anticoagulants | 5 | 2023 | 4600 | 0.180 |
Why?
|
Aneurysm, Infected | 1 | 2020 | 85 | 0.180 |
Why?
|
Echocardiography, Four-Dimensional | 1 | 2019 | 16 | 0.170 |
Why?
|
Lower Extremity | 3 | 2022 | 1158 | 0.170 |
Why?
|
Angiopoietin-2 | 1 | 2020 | 172 | 0.170 |
Why?
|
Humans | 42 | 2023 | 744366 | 0.170 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2019 | 242 | 0.160 |
Why?
|
Pulmonary Embolism | 2 | 2022 | 2375 | 0.160 |
Why?
|
Antigens, CD19 | 1 | 2020 | 380 | 0.160 |
Why?
|
Aneurysm, False | 1 | 2020 | 276 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2020 | 547 | 0.150 |
Why?
|
Equipment and Supplies | 1 | 2020 | 281 | 0.150 |
Why?
|
Nasopharynx | 1 | 2020 | 379 | 0.150 |
Why?
|
Intensive Care Units | 2 | 2021 | 3680 | 0.150 |
Why?
|
T-Box Domain Proteins | 1 | 2019 | 471 | 0.140 |
Why?
|
Prospective Studies | 9 | 2023 | 53290 | 0.140 |
Why?
|
Stroke | 3 | 2023 | 9981 | 0.140 |
Why?
|
Treatment Outcome | 8 | 2023 | 63107 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 2 | 2020 | 4042 | 0.140 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2023 | 3070 | 0.130 |
Why?
|
Safety | 1 | 2020 | 1186 | 0.130 |
Why?
|
Hindlimb | 1 | 2017 | 504 | 0.130 |
Why?
|
Metformin | 1 | 2022 | 836 | 0.130 |
Why?
|
Regional Blood Flow | 1 | 2019 | 1525 | 0.130 |
Why?
|
France | 3 | 2021 | 517 | 0.130 |
Why?
|
Echocardiography, Doppler | 1 | 2019 | 935 | 0.130 |
Why?
|
Echocardiography | 4 | 2021 | 5099 | 0.130 |
Why?
|
Motion | 1 | 2018 | 798 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.120 |
Why?
|
Stress, Mechanical | 1 | 2019 | 1686 | 0.120 |
Why?
|
Thromboembolism | 1 | 2021 | 987 | 0.120 |
Why?
|
Qualitative Research | 1 | 2023 | 2682 | 0.120 |
Why?
|
Risk Factors | 8 | 2023 | 72296 | 0.120 |
Why?
|
Iatrogenic Disease | 1 | 2017 | 547 | 0.120 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1862 | 0.120 |
Why?
|
Endothelium, Vascular | 3 | 2021 | 4459 | 0.120 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3242 | 0.120 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2022 | 1186 | 0.110 |
Why?
|
Severity of Illness Index | 4 | 2023 | 15535 | 0.110 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2019 | 691 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.100 |
Why?
|
Databases, Genetic | 1 | 2019 | 1783 | 0.100 |
Why?
|
Thrombosis | 2 | 2022 | 2968 | 0.100 |
Why?
|
Hospital Mortality | 5 | 2021 | 5316 | 0.090 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 1941 | 0.090 |
Why?
|
Cohort Studies | 2 | 2023 | 40559 | 0.090 |
Why?
|
Acute Disease | 1 | 2021 | 7147 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3511 | 0.090 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1832 | 0.090 |
Why?
|
Asymptomatic Diseases | 2 | 2023 | 551 | 0.090 |
Why?
|
Aged | 12 | 2022 | 163288 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3954 | 0.080 |
Why?
|
Middle Aged | 13 | 2022 | 213390 | 0.080 |
Why?
|
Patient Admission | 3 | 2021 | 1380 | 0.080 |
Why?
|
Coronary Angiography | 1 | 2020 | 4576 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3255 | 0.080 |
Why?
|
Heart Rate | 1 | 2019 | 4092 | 0.080 |
Why?
|
Blood Pressure | 2 | 2023 | 8551 | 0.070 |
Why?
|
Male | 17 | 2022 | 350115 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2022 | 77460 | 0.070 |
Why?
|
Obesity | 1 | 2009 | 12746 | 0.070 |
Why?
|
Feasibility Studies | 3 | 2021 | 5077 | 0.070 |
Why?
|
Pandemics | 3 | 2021 | 8385 | 0.070 |
Why?
|
Adult | 10 | 2021 | 214052 | 0.070 |
Why?
|
Protein Multimerization | 2 | 2021 | 971 | 0.070 |
Why?
|
Phenotype | 2 | 2021 | 16367 | 0.060 |
Why?
|
Blood Coagulation | 2 | 2021 | 1127 | 0.060 |
Why?
|
Female | 13 | 2021 | 380193 | 0.060 |
Why?
|
Arteries | 1 | 2009 | 1119 | 0.060 |
Why?
|
ROC Curve | 2 | 2021 | 3528 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6486 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 12073 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2019 | 4583 | 0.050 |
Why?
|
Chronic Disease | 1 | 2017 | 9145 | 0.050 |
Why?
|
Risk Reduction Behavior | 1 | 2009 | 1125 | 0.050 |
Why?
|
Animals | 5 | 2020 | 168768 | 0.050 |
Why?
|
Phantoms, Imaging | 2 | 2021 | 2480 | 0.050 |
Why?
|
Vibration | 1 | 2023 | 326 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25039 | 0.050 |
Why?
|
Thrombelastography | 1 | 2022 | 164 | 0.050 |
Why?
|
Patients' Rooms | 1 | 2021 | 63 | 0.050 |
Why?
|
Delphi Technique | 1 | 2023 | 779 | 0.050 |
Why?
|
Signal Transduction | 1 | 2023 | 23404 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6539 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1107 | 0.040 |
Why?
|
Platelet Aggregation | 1 | 2022 | 798 | 0.040 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2569 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39052 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11726 | 0.040 |
Why?
|
Receptors, Notch | 1 | 2023 | 739 | 0.040 |
Why?
|
Upper Extremity | 1 | 2023 | 648 | 0.040 |
Why?
|
Molecular Weight | 1 | 2021 | 2255 | 0.040 |
Why?
|
Tachycardia | 1 | 2020 | 619 | 0.040 |
Why?
|
E-Selectin | 1 | 2020 | 579 | 0.040 |
Why?
|
Hemostasis | 1 | 2020 | 458 | 0.040 |
Why?
|
Ticlopidine | 1 | 2023 | 899 | 0.040 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 337 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1655 | 0.040 |
Why?
|
Hospitalization | 3 | 2021 | 10259 | 0.040 |
Why?
|
Cardiac Output | 1 | 2019 | 854 | 0.040 |
Why?
|
Prognosis | 3 | 2021 | 29060 | 0.030 |
Why?
|
Mass Screening | 2 | 2022 | 5253 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12356 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2021 | 19905 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 16715 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 923 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2960 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2020 | 1572 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2023 | 2703 | 0.030 |
Why?
|
Prevalence | 2 | 2020 | 15221 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1516 | 0.030 |
Why?
|
Chest Pain | 1 | 2020 | 1114 | 0.030 |
Why?
|
Femoral Artery | 1 | 2017 | 845 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2020 | 1320 | 0.030 |
Why?
|
Blood Platelets | 1 | 2022 | 2509 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57776 | 0.030 |
Why?
|
Mice | 1 | 2018 | 81201 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3283 | 0.020 |
Why?
|
Rabbits | 1 | 2017 | 4894 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2020 | 1392 | 0.020 |
Why?
|
Stents | 1 | 2023 | 3282 | 0.020 |
Why?
|
Calibration | 1 | 2011 | 816 | 0.020 |
Why?
|
Myocardium | 1 | 2021 | 4772 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2020 | 3107 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8642 | 0.020 |
Why?
|
Heart | 1 | 2021 | 4464 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3420 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6194 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2020 | 3486 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3638 | 0.020 |
Why?
|
Child | 2 | 2021 | 77709 | 0.020 |
Why?
|
Critical Care | 1 | 2020 | 2647 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20130 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12788 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3666 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 9955 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2021 | 4468 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9445 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9857 | 0.010 |
Why?
|
Liver | 1 | 2018 | 7475 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21748 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 25628 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12262 | 0.010 |
Why?
|
Infant | 1 | 2021 | 35134 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18034 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40075 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 41005 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56429 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15160 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 85779 | 0.010 |
Why?
|